Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Express Scripts Gains from Increased Generic Utilization
by Zacks Equity Research
On Jun 27, we issued an updated research report on St. Louis, MO-based pharmacy benefit manager Express Scripts Holding Company (ESRX).
Aetna Inks New Deal to Improve Healthcare in North Carolina
by Zacks Equity Research
Aetna, Inc. (AET) recently inked a deal with Community Care Physician Network, LLC
Centene's (CNC) Unit Secures Medicaid Contract in Mississipi
by Zacks Equity Research
The Mississippi subsidiary of Centene Corp. (CNC), Magnolia Health, will be serving Medicaid enrollees in the region. Medicaid is the state-federal program.
Anthem Quits 2 More Exchanges Amid Regulatory Uncertainty
by Zacks Equity Research
Anthem Inc. (ANTM) is quitting public exchange markets in the states of Wisconsin and Indiana for 2018.
Looking for Value? Why It Might Be Time to Try Anthem (ANTM)
by Zacks Equity Research
Anthem (ANTM) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
Is Anthem (ANTM) a Great Stock for Value Investors?
by Zacks Equity Research
Let's see if Anthem, Inc. (ANTM) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Zacks.com featured highlights: Darden Restaurants, EMCOR Group, Anthem, Humana and Vodafone Group
by Zacks Equity Research
Zacks.com featured highlights: Darden Restaurants, EMCOR Group, Anthem, Humana and Vodafone Group
Buy these 5 Low Leverage Stocks as Market Hits Record High
by Zacks Equity Research
Since volatility can hit the global markets any time, it is wise to choose less risky stocks. Companies with a lower level of debt are considered safe bets.
5 Dividend Growth Stocks that Ensure Safe Returns
by Sweta Killa
Honing in on dividend is a tried-and-true practice during market turbulence.
Why the Earnings Streak Will Continue for Anthem (ANTM)
by Zacks Equity Research
Anthem (ANTM) boasts a favorable Zacks Rank and a positive Earnings ESP, which is a great sign of a coming earnings beat.
4 Reasons to Stay Away from Mednax (MD) Now
by Zacks Equity Research
Mednax (MD) is suffering from subdued pace of birth across the country, which has slowed the growth of one of its core businesses, neonatology.
Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and Molina Healthcare
by Zacks Equity Research
Zacks Industry Outlook Highlights: Anthem, Cigna, Aetna, Humana and Molina Healthcare
Teladoc Hits 52-Week High on Strong Results, Client Wins
by Zacks Equity Research
Teladoc's (TDOC) 52-week high is believed to have been driven by the company's better-than-expected first-quarter earnings along with the recent news of expansion of its telehealth offerings in Texas.
Will Health Insurers Have to Rework Under ACHA?
by Zacks Equity Research
The overall expectation is that the new regulatory framework will provide for a relatively lighter regulatory touch and will be friendlier to the industry. That said, the expected change would have some negative effects on the industry as well.
Health Insurance Industry Outlook - June 2017
by Zacks Equity Research
The CBO has estimated that while the proposed legislation will bring down the deficit and cut government spending, it will also cause the loss of insurance for 23 million people.
Zacks.com featured highlights: Darden Restaurants, Schnitzer Steel Industries, Anthem, Humana and Vodafone Group
by Zacks Equity Research
Zacks.com featured highlights: Darden Restaurants, Schnitzer Steel Industries, Anthem, Humana and Vodafone Group
Buy these 5 Low Leverage Stocks to Keep your Portfolio Safe
by Zacks Equity Research
The U.S. stock market recovered last Friday, driven by positive market sentiment with two significant data points for the month of May expected shortly. The consumer confidence figures will be released today while the jobs report is due on Friday.
Zacks.com featured highlights: MKS Instruments, Westlake Chemical, Anthem, Lear and Lazard
by Zacks Equity Research
Zacks.com featured highlights: MKS Instruments, Westlake Chemical, Anthem, Lear and Lazard
Top Ranked Value Stocks to Buy for May 19th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, May 19th:
Weakness Seen in Triple-S Management (GTS) Estimates: Should You Stay Away?
by Zacks Equity Research
Triple-S Management (GTS) is one stock you should avoid as it has seen a significant price decline and negative earnings estimate revisions.
Anthem Finally Walks Away from Cigna Merger, Seeks Charges
by Zacks Equity Research
Anthem Inc. (ANTM) has officially terminated its merger with Cigna.
Zacks.com featured highlights: Darden Restaurants, Alphabet, Anthem, Humana and Nucor
by Zacks Equity Research
Zacks.com featured highlights: Darden Restaurants, Alphabet, Anthem, Humana and Nucor
3 Reasons Why Anthem (ANTM) is a Great Momentum Stock
by Zacks Equity Research
Anthem (ANTM) is a solid momentum stock that has a favorable Zacks Rank and is seeing solid earnings estimate revisions.
Worried About Volatility? Buy these 5 Low Leverage Stocks
by Zacks Equity Research
Considering the fact that sudden variability can hit the global market any time, it is better to choose stocks that bear relatively less risk. One of the investment strategies to choose less risky stocks is to measure a company's debt level.
Aetna (AET) Calls it Quits on Unsustainable Public Exchanges
by Zacks Equity Research
In the wake of continued loss incurred by its public exchange business, health insurer Aetna Inc. (AET) has announced to pull back its presence.